We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
(+5.9%)
Cap. Flow
-$501M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$417M |
| 2 |
Meta Platforms (Facebook)
META
|
+$383M |
| 3 |
Amazon
AMZN
|
+$308M |
| 4 |
Microsoft
MSFT
|
+$293M |
| 5 |
GE Aerospace
GE
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$312M |
| 2 |
Bank of America
BAC
|
+$292M |
| 3 |
ExxonMobil
XOM
|
+$274M |
| 4 |
lululemon athletica
LULU
|
+$238M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.05% |
| 2 | Technology | 14.35% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 9.9% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Replimune Group
REPL
$724M
| $11.4M | 0.02% |
646,888
+520,321
| +411% | +$12.4M |
|
652
Sinclair Inc
SBGI
$974M
| $11.4M | 0.02% |
664,898
+367,791
| +124% | +$6.4M |
|
653
Yum China
YUMC
$15.3B
| $11.3M | 0.02% |
178,110
-716,380
| -80% | -$43.2M |
|
654
Frontline
FRO
$8.59B
| $11.3M | 0.02% |
681,565
+398,062
| +140% | +$6.26M |
|
|
VMEO
655
DELISTED
Vimeo
VMEO
| $11.3M | 0.02% |
2,944,809
+2,626,384
| +825% | +$10.3M |
|
|
FLD
656
Fold Holdings
FLD
$22.9M
| $11.3M | 0.02% |
1,103,494
| – | – |
|
657
Dycom Industries
DY
$12.7B
| $11.2M | 0.02% |
+120,084
| New | +$11.2M |
|
658
Cadence Design Systems
CDNS
$93.4B
| $11.2M | 0.02% |
53,458
+12,169
| +29% | +$2.3M |
|
659
Mondelez International
MDLZ
$77.9B
| $11.2M | 0.02% |
160,554
-105,201
| -40% | -$6.97M |
|
660
Encompass Health
EHC
$11.3B
| $11.2M | 0.02% |
+206,553
| New | +$12M |
|
661
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
| $11.2M | 0.02% |
+347,154
| New | +$12.1M |
|
662
Arcos Dorados Holdings
ARCO
$1.75B
| $11.1M | 0.02% |
1,444,614
-460,096
| -24% | -$3.78M |
|
663
Doximity
DOCS
$3.77B
| $11.1M | 0.02% |
343,886
+73,914
| +27% | +$2.45M |
|
664
Paycom
PAYC
$7.05B
| $11.1M | 0.02% |
36,511
-88,001
| -71% | -$26.5M |
|
665
Cameco
CCJ
$38.9B
| $11M | 0.02% |
421,157
-159,720
| -27% | -$4.22M |
|
|
BLU
666
DELISTED
BELLUS Health Inc.
BLU
| $10.9M | 0.02% |
1,520,633
-61,532
| -4% | -$477K |
|
667
Zillow
Z
$7.32B
| $10.9M | 0.02% |
244,337
-84,246
| -26% | -$3.58M |
|
|
NVMI
668
Nova
NVMI
$13.6B
| $10.8M | 0.02% |
103,608
+38,362
| +59% | +$3.59M |
|
|
JAMF
669
DELISTED
Jamf
JAMF
| $10.8M | 0.02% |
556,738
+215,280
| +63% | +$4.31M |
|
670
Constellation Energy
CEG
$96.4B
| $10.8M | 0.02% |
+137,175
| New | +$11.1M |
|
671
Liberty Media Series A
FWONA
$22.6B
| $10.8M | 0.02% |
166,477
+49,593
| +42% | +$2.99M |
|
672
Innovative Industrial Properties
IIPR
$1.78B
| $10.8M | 0.02% |
141,559
+54,969
| +63% | +$4.85M |
|
673
Cactus
WHD
$3.74B
| $10.7M | 0.02% |
+259,815
| New | +$12.5M |
|
|
TGR
674
DELISTED
Kimbell Tiger Acquisition Corporation
TGR
| $10.7M | 0.02% |
1,017,244
| – | – |
|
675
Eversource Energy
ES
$28.1B
| $10.7M | 0.02% |
+136,742
| New | +$10.8M |
|
Similar funds
Marshall Wace's Q1 2023 Portfolio in Review
As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
- Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
- Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
- Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
- Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
- Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
- Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.
Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.